marketcaparena
Search

    ILMN

    ILLUMINA, INC.

    Company overview

    Market capitalization
    $41.06B
    Employees
    8,600
    Latest publication
    2026-09-29
    About ILLUMINA, INC.

    Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20272026-06-28 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue1,159,000,000USD1,091,000,000USD1,160,000,000USD1,083,000,000USD1,057,000,000USD1,041,000,000USD1,104,000,000USD1,080,000,000USD
    Cost Of Revenue389,000,000USD347,000,000USD382,000,000USD351,000,000USD340,000,000USD356,000,000USD376,000,000USD335,000,000USD
    Gross Profit770,000,000USD744,000,000USD778,000,000USD732,000,000USD717,000,000USD685,000,000USD728,000,000USD745,000,000USD
    Research Development252,000,000USD240,000,000USD238,000,000USD228,000,000USD243,000,000USD241,000,000USD255,000,000USD253,000,000USD
    Selling General Administrative273,000,000USD272,000,000USD283,000,000USD277,000,000USD241,000,000USD267,000,000USD279,000,000USD239,000,000USD
    Total Operating Expenses525,000,000USD512,000,000USD521,000,000USD501,000,000USD495,000,000USD501,000,000USD526,000,000USD4,000,000USD
    Operating Income245,000,000USD232,000,000USD257,000,000USD231,000,000USD222,000,000USD184,000,000USD202,000,000USD741,000,000USD
    Total Other Income Expense Net15,000,000USD-75,000,000USD121,000,000USD-11,000,000USD84,000,000USD-2,000,000USD-14,000,000USD-21,000,000USD
    Interest Income8,000,000USD11,000,000USD192,000,000USD9,000,000USD102,000,000USD11,000,000USD10,000,000USD11,000,000USD
    Interest Expense24,000,000USD24,000,000USD26,000,000USD25,000,000USD25,000,000USD25,000,000USD25,000,000USD36,000,000USD
    Income Before Tax260,000,000USD157,000,000USD378,000,000USD220,000,000USD306,000,000USD182,000,000USD188,000,000USD720,000,000USD
    Income Tax Expense53,000,000USD23,000,000USD44,000,000USD70,000,000USD71,000,000USD51,000,000USD1,000,000USD15,000,000USD
    Net Income207,000,000USD134,000,000USD334,000,000USD150,000,000USD235,000,000USD131,000,000USD187,000,000USD705,000,000USD
    Net Interest Income—-13,000,000USD-16,000,000USD-16,000,000USD-15,000,000USD-14,000,000USD-15,000,000USD-25,000,000USD
    Tax Provision—23,000,000USD44,000,000USD70,000,000USD71,000,000USD51,000,000USD0USD15,000,000USD
    Net Income From Continuing Ops—134,000,000USD334,000,000USD150,000,000USD235,000,000USD131,000,000USD187,000,000USD705,000,000USD
    Ebit—157,000,000USD404,000,000USD245,000,000USD331,000,000USD184,000,000USD212,000,000USD756,000,000USD
    Ebitda—226,000,000USD471,000,000USD312,000,000USD399,000,000USD253,000,000USD283,000,000USD826,000,000USD
    Depreciation And Amortization—69,000,000USD67,000,000USD67,000,000USD68,000,000USD69,000,000USD71,000,000USD70,000,000USD
    Reconciled Depreciation—69,000,000USD66,000,000USD67,000,000USD68,000,000USD69,000,000USD71,000,000USD70,000,000USD
    Net Income Applicable To Common Shares——334,000,000USD150,000,000USD235,000,000USD131,000,000USD187,000,000USD705,000,000USD
    Unclassified Operating Expenses————11,000,000USD-7,000,000USD-8,000,000USD-488,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20222022-12-31 · USDFY 20202020-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USDFY 20122012-12-31 · USDFY 20112011-12-31 · USD
    Total Revenue4,338,000,000USD4,584,000,000USD3,239,000,000USD2,219,762,000USD1,861,358,000USD1,421,178,000USD1,148,516,000USD1,055,535,000USD
    Cost Of Revenue1,445,000,000USD1,612,000,000USD1,036,000,000USD671,000,000USD563,648,000USD509,291,000USD374,988,000USD346,437,000USD
    Gross Profit2,893,000,000USD2,972,000,000USD2,203,000,000USD1,549,000,000USD1,297,710,000USD911,887,000USD773,528,000USD709,098,000USD
    Research Development951,000,000USD1,321,000,000USD682,000,000USD401,527,000USD388,055,000USD276,743,000USD231,025,000USD196,913,000USD
    Selling General Administrative1,031,000,000USD1,297,000,000USD941,000,000USD524,657,000USD463,500,000USD13,621,000USD23,136,000USD261,800,000USD
    Unclassified Operating Expenses47,000,000USD303,000,000USD—9,816,000USD-68,556,000USD119,997,000USD55,760,000USD50,924,000USD
    Total Operating Expenses2,029,000,000USD7,151,000,000USD1,623,000,000USD936,000,000USD782,999,000USD777,780,000USD572,776,000USD509,637,000USD
    Operating Income864,000,000USD-4,179,000,000USD393,000,000USD613,000,000USD514,711,000USD134,107,000USD200,752,000USD199,461,000USD
    Interest Income333,000,000USD11,000,000USD41,000,000USD21,496,000USD————
    Interest Expense101,000,000USD26,000,000USD49,000,000USD43,000,000USD41,728,000USD39,690,000USD37,779,000USD34,790,000USD
    Net Interest Income-61,000,000USD-15,000,000USD-8,000,000USD—————
    Income Before Tax1,086,000,000USD-4,336,000,000USD856,000,000USD583,000,000USD448,758,000USD159,314,000USD222,608,000USD133,045,000USD
    Income Tax Expense236,000,000USD68,000,000USD200,000,000USD125,000,000USD95,407,000USD34,006,000USD71,354,000USD46,417,000USD
    Tax Provision236,000,000USD68,000,000USD200,000,000USD125,752,000USD————
    Net Income850,000,000USD-4,404,000,000USD656,000,000USD461,559,000USD353,351,000USD125,308,000USD151,254,000USD86,628,000USD
    Net Income From Continuing Ops850,000,000USD-4,404,000,000USD656,000,000USD457,390,000USD353,351,000USD125,308,000USD151,254,000USD86,628,000USD
    Ebit1,187,000,000USD-4,179,000,000USD393,000,000USD626,000,000USD490,486,000USD199,004,000USD260,387,000USD167,835,000USD
    Ebitda1,457,000,000USD-3,785,000,000USD580,000,000USD753,000,000USD603,060,000USD296,929,000USD325,706,000USD237,027,000USD
    Depreciation And Amortization270,000,000USD394,000,000USD187,000,000USD127,000,000USD112,574,000USD97,925,000USD65,319,000USD69,192,000USD
    Reconciled Depreciation270,000,000USD394,000,000USD187,000,000USD—————
    Total Other Income Expense Net222,000,000USD-8,829,000,000USD463,000,000USD-30,000,000USD-65,953,000USD25,207,000USD21,856,000USD-66,416,000USD
    Net Income Applicable To Common Shares850,000,000USD-4,404,000,000USD656,000,000USD461,559,000USD353,351,000USD125,308,000USD151,254,000USD86,628,000USD
    Other Operating Expenses—4,230,000,000USD——————
    Non Operating Income Net Other—-157,000,000USD325,000,000USD12,422,000USD-24,225,000USD64,897,000USD59,635,000USD-31,626,000USD
    Minority Interest——0USD-4,169,000USD32,546,000USD———
    Selling And Marketing Expenses—————367,419,000USD262,855,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20272026-06-28 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets6,650,000,000USD6,559,000,000USD6,644,000,000USD6,177,000,000USD6,087,000,000USD6,182,000,000USD6,303,000,000USD6,014,000,000USD
    Short Term Investments128,000,000USD66,000,000USD215,000,000USD228,000,000USD221,000,000USD124,000,000USD93,000,000USD70,000,000USD
    Total Current Assets2,834,000,000USD2,738,000,000USD3,289,000,000USD2,796,000,000USD2,641,000,000USD2,673,000,000USD2,746,000,000USD2,373,000,000USD
    Other Current Assets273,000,000USD234,000,000USD238,000,000USD177,000,000USD195,000,000USD185,000,000USD228,000,000USD145,000,000USD
    Other Non Current Assets576,000,000USD———————
    Total Liabilities3,812,000,000USD———————
    Total Current Liabilities1,578,000,000USD1,566,000,000USD1,585,000,000USD1,962,000,000USD1,461,000,000USD1,440,000,000USD1,547,000,000USD975,000,000USD
    Other Current Liabilities848,000,000USD———————
    Other Non Current Liabilities289,000,000USD———————
    Total Stockholder Equity2,838,000,000USD2,676,000,000USD2,723,000,000USD2,381,000,000USD2,258,000,000USD2,368,000,000USD2,373,000,000USD2,125,000,000USD
    Total Equity Including Noncontrolling Interest2,838,000,000USD———————
    Deferred Revenue261,000,000USD———————
    Net Receivables764,000,000USD738,000,000USD854,000,000USD751,000,000USD716,000,000USD714,000,000USD751,000,000USD715,000,000USD
    Inventory629,000,000USD611,000,000USD564,000,000USD590,000,000USD575,000,000USD537,000,000USD547,000,000USD574,000,000USD
    Property Plant Equipment Net1,107,000,000USD1,126,000,000USD1,129,000,000USD1,130,000,000USD1,161,000,000USD1,192,000,000USD1,234,000,000USD1,285,000,000USD
    Goodwill1,284,000,000USD———————
    Intangible Assets410,000,000USD430,000,000USD210,000,000USD225,000,000USD238,000,000USD278,000,000USD295,000,000USD305,000,000USD
    Accounts Payable230,000,000USD218,000,000USD240,000,000USD218,000,000USD200,000,000USD207,000,000USD221,000,000USD191,000,000USD
    Short Term Debt82,000,000USD579,000,000USD577,000,000USD1,076,000,000USD578,000,000USD577,000,000USD578,000,000USD73,000,000USD
    Common Stock2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
    Retained Earnings-51,000,000USD-258,000,000USD-392,000,000USD-726,000,000USD-876,000,000USD-1,111,000,000USD-1,242,000,000USD-1,428,000,000USD
    Accumulated Other Comprehensive Income8,000,000USD1,000,000USD-10,000,000USD-12,000,000USD-21,000,000USD8,000,000USD22,000,000USD-5,000,000USD
    Cash And Equivalents1,040,000,000USD—1,418,000,000USD1,050,000,000USD934,000,000USD1,113,000,000USD1,127,000,000USD869,000,000USD
    Total Liab—3,883,000,000USD3,921,000,000USD3,796,000,000USD3,829,000,000USD3,814,000,000USD3,930,000,000USD3,889,000,000USD
    Other Current Liab—500,000,000USD498,000,000USD434,000,000USD436,000,000USD320,000,000USD387,000,000USD476,000,000USD
    Capital Stock—2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
    Good Will—1,284,000,000USD1,113,000,000USD1,113,000,000USD1,113,000,000USD1,113,000,000USD1,113,000,000USD1,113,000,000USD
    Cash—1,089,000,000USD1,418,000,000USD1,050,000,000USD934,000,000USD1,113,000,000USD1,127,000,000USD869,000,000USD
    Cash And Short Term Investments—1,155,000,000USD1,633,000,000USD1,278,000,000USD1,155,000,000USD1,237,000,000USD1,220,000,000USD939,000,000USD
    Current Deferred Revenue—269,000,000USD270,000,000USD234,000,000USD247,000,000USD256,000,000USD260,000,000USD235,000,000USD
    Net Debt—1,455,000,000USD1,135,000,000USD1,526,000,000USD1,664,000,000USD1,494,000,000USD1,495,000,000USD1,805,000,000USD
    Short Long Term Debt—499,000,000USD499,000,000USD998,000,000USD499,000,000USD499,000,000USD499,000,000USD—
    Short Long Term Debt Total—2,544,000,000USD2,553,000,000USD2,576,000,000USD2,598,000,000USD2,607,000,000USD2,622,000,000USD2,674,000,000USD
    Long Term Debt—1,490,000,000USD1,490,000,000USD994,000,000USD1,492,000,000USD1,491,000,000USD1,490,000,000USD1,988,000,000USD
    Property Plant Equipment Gross—1,126,000,000USD2,492,000,000USD1,130,000,000USD1,161,000,000USD1,192,000,000USD2,488,000,000USD1,285,000,000USD
    Common Stock Shares Outstanding—154,000,000shares154,000,000shares154,000,000shares157,000,000shares159,000,000shares160,000,000shares160,000,000shares
    Non Current Assets Total—3,821,000,000USD3,355,000,000USD3,381,000,000USD3,446,000,000USD3,509,000,000USD3,557,000,000USD3,641,000,000USD
    Non Current Liabilities Total—2,317,000,000USD2,336,000,000USD1,834,000,000USD2,368,000,000USD2,374,000,000USD2,383,000,000USD2,914,000,000USD
    Non Current Liabilities Other—352,000,000USD360,000,000USD334,000,000USD348,000,000USD344,000,000USD339,000,000USD313,000,000USD
    Non Currrent Assets Other—172,000,000USD111,000,000USD118,000,000USD107,000,000USD122,000,000USD121,000,000USD103,000,000USD
    Net Working Capital—1,172,000,000USD1,704,000,000USD834,000,000USD1,180,000,000USD1,233,000,000USD1,199,000,000USD1,398,000,000USD
    Unclassified Non Current Assets—809,000,000USD-111,000,000USD155,000,000USD-107,000,000USD129,000,000USD106,000,000USD115,000,000USD
    Unclassified Current Liabilities—-499,000,000USD-499,000,000USD-998,000,000USD-499,000,000USD-419,000,000USD-398,000,000USD—
    Unclassified Non Current Liabilities—475,000,000USD486,000,000USD506,000,000USD528,000,000USD539,000,000USD554,000,000USD613,000,000USD
    Unclassified Equity—2,929,000,000USD3,121,000,000USD3,115,000,000USD3,151,000,000USD3,467,000,000USD3,589,000,000USD3,554,000,000USD
    Other Assets——903,000,000USD640,000,000USD934,000,000USD675,000,000USD688,000,000USD720,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets6,644,000,000USD6,303,000,000USD10,111,000,000USD12,252,000,000USD15,217,000,000USD7,585,000,000USD7,316,000,000USD6,959,000,000USD
    Intangible Assets210,000,000USD295,000,000USD2,993,000,000USD3,285,000,000USD3,250,000,000USD142,000,000USD145,000,000USD185,000,000USD
    Other Current Assets238,000,000USD228,000,000USD216,000,000USD268,000,000USD279,000,000USD152,000,000USD105,000,000USD78,000,000USD
    Total Liab3,921,000,000USD3,930,000,000USD4,366,000,000USD5,653,000,000USD4,477,000,000USD2,891,000,000USD2,703,000,000USD3,053,000,000USD
    Total Stockholder Equity2,723,000,000USD2,373,000,000USD5,745,000,000USD6,599,000,000USD10,740,000,000USD4,694,000,000USD4,613,000,000USD3,845,000,000USD
    Other Current Liab498,000,000USD387,000,000USD908,000,000USD814,000,000USD358,000,000USD236,000,000USD218,000,000USD256,000,000USD
    Common Stock2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
    Capital Stock2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD2,000,000USD
    Retained Earnings-392,000,000USD-1,242,000,000USD-19,000,000USD1,142,000,000USD5,485,000,000USD4,723,000,000USD4,067,000,000USD3,083,000,000USD
    Good Will1,113,000,000USD1,113,000,000USD2,545,000,000USD3,239,000,000USD7,113,000,000USD897,000,000USD824,000,000USD831,000,000USD
    Other Assets903,000,000USD688,000,000USD217,000,000USD212,000,000USD445,000,000USD609,000,000USD179,000,000USD118,000,000USD
    Cash1,418,000,000USD1,127,000,000USD1,048,000,000USD2,011,000,000USD1,232,000,000USD1,810,000,000USD2,042,000,000USD1,144,000,000USD
    Cash And Equivalents1,418,000,000USD1,127,000,000USD1,048,000,000USD2,011,000,000USD1,232,000,000USD1,810,000,000USD——
    Cash And Short Term Investments1,633,000,000USD1,220,000,000USD1,054,000,000USD2,037,000,000USD1,339,000,000USD3,472,000,000USD3,414,000,000USD3,512,000,000USD
    Total Current Assets3,289,000,000USD2,746,000,000USD2,609,000,000USD3,561,000,000USD2,713,000,000USD4,483,000,000USD4,451,000,000USD4,490,000,000USD
    Total Current Liabilities1,585,000,000USD1,547,000,000USD1,570,000,000USD2,773,000,000USD1,093,000,000USD1,244,000,000USD665,000,000USD1,804,000,000USD
    Current Deferred Revenue270,000,000USD260,000,000USD252,000,000USD245,000,000USD234,000,000USD186,000,000USD167,000,000USD175,000,000USD
    Net Debt1,135,000,000USD1,495,000,000USD1,214,000,000USD1,544,000,000USD1,308,000,000USD96,000,000USD-161,000,000USD853,000,000USD
    Short Term Debt577,000,000USD578,000,000USD86,000,000USD1,324,000,000USD71,000,000USD562,000,000USD45,000,000USD1,107,000,000USD
    Short Long Term Debt499,000,000USD499,000,000USD—1,248,000,000USD—511,000,000USD—1,107,000,000USD
    Short Long Term Debt Total2,553,000,000USD2,622,000,000USD2,262,000,000USD3,555,000,000USD2,540,000,000USD1,906,000,000USD1,881,000,000USD1,997,000,000USD
    Long Term Debt1,490,000,000USD1,490,000,000USD1,489,000,000USD1,487,000,000USD1,695,000,000USD673,000,000USD1,141,000,000USD890,000,000USD
    Short Term Investments215,000,000USD93,000,000USD6,000,000USD26,000,000USD107,000,000USD1,662,000,000USD1,372,000,000USD2,368,000,000USD
    Net Receivables854,000,000USD751,000,000USD752,000,000USD688,000,000USD664,000,000USD487,000,000USD573,000,000USD514,000,000USD
    Inventory564,000,000USD547,000,000USD587,000,000USD568,000,000USD431,000,000USD372,000,000USD359,000,000USD386,000,000USD
    Accounts Payable240,000,000USD221,000,000USD245,000,000USD293,000,000USD332,000,000USD192,000,000USD149,000,000USD184,000,000USD
    Property Plant Equipment Net1,129,000,000USD1,234,000,000USD1,551,000,000USD1,744,000,000USD1,696,000,000USD1,454,000,000USD1,444,000,000USD1,075,000,000USD
    Property Plant Equipment Gross2,492,000,000USD2,488,000,000USD2,689,000,000USD1,744,000,000USD1,696,000,000USD1,454,000,000USD1,444,000,000USD1,075,000,000USD
    Accumulated Other Comprehensive Income-10,000,000USD22,000,000USD-1,000,000USD3,000,000USD17,000,000USD2,000,000USD5,000,000USD-1,000,000USD
    Common Stock Shares Outstanding156,000,000shares159,000,000shares158,000,000shares157,000,000shares151,000,000shares148,000,000shares149,000,000shares149,000,000shares
    Non Current Assets Total3,355,000,000USD3,557,000,000USD7,502,000,000USD8,691,000,000USD12,504,000,000USD3,102,000,000USD2,865,000,000USD2,469,000,000USD
    Non Current Liabilities Total2,336,000,000USD2,383,000,000USD2,796,000,000USD2,880,000,000USD3,384,000,000USD1,647,000,000USD2,038,000,000USD1,310,000,000USD
    Non Current Liabilities Other360,000,000USD339,000,000USD620,000,000USD649,000,000USD915,000,000USD303,000,000USD202,000,000USD359,000,000USD
    Non Currrent Assets Other111,000,000USD121,000,000USD217,000,000USD212,000,000USD232,000,000USD171,000,000USD105,000,000USD48,000,000USD
    Net Working Capital1,704,000,000USD1,199,000,000USD1,039,000,000USD788,000,000USD1,620,000,000USD3,239,000,000USD3,786,000,000USD2,686,000,000USD
    Unclassified Non Current Assets-111,000,000USD106,000,000USD——-232,000,000USD-171,000,000USD-105,000,000USD-48,000,000USD
    Unclassified Current Liabilities-499,000,000USD-398,000,000USD79,000,000USD-1,151,000,000USD98,000,000USD-443,000,000USD86,000,000USD-1,025,000,000USD
    Unclassified Non Current Liabilities486,000,000USD554,000,000USD687,000,000USD-610,000,000USD-846,000,000USD368,000,000USD493,000,000USD-298,000,000USD
    Unclassified Equity3,121,000,000USD3,589,000,000USD5,761,000,000USD5,450,000,000USD8,936,000,000USD3,813,000,000USD3,558,000,000USD3,375,000,000USD
    Deferred Long Term Liab———705,000,000USD705,000,000USD———
    Other Liab———649,000,000USD915,000,000USD303,000,000USD202,000,000USD359,000,000USD
    Net Tangible Assets———4,058,000,000USD377,000,000USD4,326,000,000USD4,339,000,000USD2,803,000,000USD
    Treasury Stock————-3,702,000,000USD-3,848,000,000USD-3,021,000,000USD-2,616,000,000USD
    Long Term Investments——————273,000,000USD260,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20272026-06-28 · USD
    Depreciation139,000,000USD
    Stock Based Compensation133,000,000USD
    Other Non Cash Items-4,000,000USD
    Change To Account Receivables92,000,000USD
    Change To Inventory-31,000,000USD
    Change To Liabilities-90,000,000USD
    Change In Working Capital-22,000,000USD
    Operating Cash Flow490,000,000USD
    Capital Expenditures-78,000,000USD
    Other Investing Activities-417,000,000USD
    Unclassified Investing Cash Flow7,000,000USD
    Investing Cash Flow-488,000,000USD
    Net Common Stock Issuance-403,000,000USD
    Unclassified Financing Cash Flow23,000,000USD
    Financing Cash Flow-380,000,000USD
    Effect Of Forex Changes On Cash0USD
    Change In Cash-378,000,000USD
    End Cash Flow1,040,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income134,000,000USD334,000,000USD150,000,000USD131,000,000USD187,000,000USD704,000,000USD-1,988,000,000USD-126,000,000USD
    Depreciation69,000,000USD67,000,000USD67,000,000USD69,000,000USD71,000,000USD70,000,000USD105,000,000USD108,000,000USD
    Stock Based Compensation60,000,000USD63,000,000USD70,000,000USD73,000,000USD79,000,000USD83,000,000USD112,000,000USD96,000,000USD
    Other Non Cash Items30,000,000USD-99,000,000USD12,000,000USD-45,000,000USD-24,000,000USD-504,000,000USD1,925,000,000USD49,000,000USD
    Change To Account Receivables118,000,000USD-121,000,000USD-36,000,000USD46,000,000USD-45,000,000USD-72,000,000USD-18,000,000USD90,000,000USD
    Change To Inventory-13,000,000USD26,000,000USD-15,000,000USD10,000,000USD28,000,000USD-4,000,000USD0USD4,000,000USD
    Change In Working Capital-1,000,000USD-18,000,000USD-56,000,000USD-4,000,000USD2,000,000USD-56,000,000USD82,000,000USD-26,000,000USD
    Total Cash From Operating Activities289,000,000USD321,000,000USD284,000,000USD240,000,000USD364,000,000USD316,000,000USD80,000,000USD77,000,000USD
    Capital Expenditures-38,000,000USD-54,000,000USD-24,000,000USD-39,000,000USD-29,000,000USD-32,000,000USD-31,000,000USD-36,000,000USD
    Free Cash Flow251,000,000USD267,000,000USD260,000,000USD201,000,000USD335,000,000USD284,000,000USD49,000,000USD41,000,000USD
    Investments87,000,000USD166,000,000USD-51,000,000USD-63,000,000USD-48,000,000USD-41,000,000USD-41,000,000USD-48,000,000USD
    Total Cashflows From Investing Activities-366,000,000USD108,000,000USD-51,000,000USD-63,000,000USD-48,000,000USD-41,000,000USD-41,000,000USD-48,000,000USD
    Total Cash From Financing Activities-251,000,000USD-63,000,000USD-115,000,000USD-195,000,000USD-47,000,000USD-332,000,000USD-226,000,000USD35,000,000USD
    Sale Purchase Of Stock-242,000,000USD-42,000,000USD-130,000,000USD-200,000,000USD-17,000,000USD-99,000,000USD-1,000,000USD-1,000,000USD
    Issuance Of Capital Stock24,000,000USD0USD16,000,000USD27,000,000USD0USD20,000,000USD0USD36,000,000USD
    Change In Cash-329,000,000USD368,000,000USD116,000,000USD-14,000,000USD258,000,000USD-51,000,000USD-188,000,000USD60,000,000USD
    Begin Period Cash Flow1,418,000,000USD1,050,000,000USD934,000,000USD1,127,000,000USD869,000,000USD920,000,000USD1,108,000,000USD1,048,000,000USD
    End Period Cash Flow1,089,000,000USD1,418,000,000USD1,050,000,000USD1,113,000,000USD1,127,000,000USD869,000,000USD920,000,000USD1,108,000,000USD
    Other Cashflows From Investing Activities-328,000,000USD162,000,000USD-20,000,000USD-7,000,000USD-19,000,000USD83,000,000USD-9,000,000USD-48,000,000USD
    Other Cashflows From Financing Activities-33,000,000USD-16,000,000USD-1,000,000USD-22,000,000USD-1,271,000,000USD-41,000,000USD-969,000,000USD-1,000,000USD
    Unclassified Operating Cash Flow-3,000,000USD-26,000,000USD41,000,000USD16,000,000USD49,000,000USD19,000,000USD-156,000,000USD-24,000,000USD
    Unclassified Investing Cash Flow-87,000,000USD-166,000,000USD44,000,000USD46,000,000USD48,000,000USD-51,000,000USD40,000,000USD84,000,000USD
    Unclassified Financing Cash Flow24,000,000USD—16,000,000USD27,000,000USD—1,302,000,000USD744,000,000USD37,000,000USD
    Net Borrowings—-5,000,000USD0USD—1,241,000,000USD-1,494,000,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income850,000,000USD-1,223,000,000USD-1,161,000,000USD-4,404,000,000USD762,000,000USD656,000,000USD990,000,000USD782,000,000USD
    Depreciation270,000,000USD354,000,000USD432,000,000USD394,000,000USD251,000,000USD187,000,000USD188,000,000USD179,000,000USD
    Stock Based Compensation275,000,000USD370,000,000USD380,000,000USD366,000,000USD754,000,000USD194,000,000USD194,000,000USD193,000,000USD
    Other Non Cash Items-282,000,000USD1,931,000,000USD950,000,000USD3,855,000,000USD-994,000,000USD-147,000,000USD-138,000,000USD24,000,000USD
    Change To Account Receivables-108,000,000USD-25,000,000USD-40,000,000USD-12,000,000USD-164,000,000USD89,000,000USD-58,000,000USD-105,000,000USD
    Change To Inventory-17,000,000USD19,000,000USD-20,000,000USD-135,000,000USD-58,000,000USD-12,000,000USD25,000,000USD-53,000,000USD
    Change In Working Capital-153,000,000USD-483,000,000USD-90,000,000USD204,000,000USD-152,000,000USD73,000,000USD-194,000,000USD-18,000,000USD
    Total Cash From Operating Activities1,079,000,000USD837,000,000USD478,000,000USD392,000,000USD545,000,000USD1,080,000,000USD1,051,000,000USD1,142,000,000USD
    Capital Expenditures-148,000,000USD-128,000,000USD-195,000,000USD-286,000,000USD-208,000,000USD-189,000,000USD-209,000,000USD-296,000,000USD
    Free Cash Flow931,000,000USD709,000,000USD282,000,000USD106,000,000USD337,000,000USD891,000,000USD842,000,000USD846,000,000USD
    Investments103,000,000USD-178,000,000USD-231,000,000USD-591,000,000USD-1,069,000,000USD-143,000,000USD1,003,000,000USD-1,402,000,000USD
    Total Cashflows From Investing Activities-55,000,000USD-178,000,000USD-231,000,000USD-591,000,000USD-1,069,000,000USD-554,000,000USD745,000,000USD-1,813,000,000USD
    Net Borrowings-5,000,000USD491,000,000USD-1,236,000,000USD991,000,000USD471,000,000USD471,000,000USD-550,000,000USD731,000,000USD
    Total Cash From Financing Activities-744,000,000USD-570,000,000USD-1,210,000,000USD1,000,000,000USD-51,000,000USD-766,000,000USD-897,000,000USD594,000,000USD
    Sale Purchase Of Stock-742,000,000USD-116,000,000USD-40,000,000USD-54,000,000USD-511,000,000USD-736,000,000USD-324,000,000USD-201,000,000USD
    Issuance Of Capital Stock44,000,000USD56,000,000USD67,000,000USD63,000,000USD60,000,000USD61,000,000USD59,000,000USD46,000,000USD
    Change In Cash291,000,000USD79,000,000USD-963,000,000USD779,000,000USD-578,000,000USD-232,000,000USD898,000,000USD-81,000,000USD
    Begin Period Cash Flow1,127,000,000USD1,048,000,000USD2,011,000,000USD1,232,000,000USD1,810,000,000USD2,042,000,000USD1,144,000,000USD1,225,000,000USD
    End Period Cash Flow1,418,000,000USD1,127,000,000USD1,048,000,000USD2,011,000,000USD1,232,000,000USD1,810,000,000USD2,042,000,000USD1,144,000,000USD
    Other Cashflows From Investing Activities103,000,000USD2,000,000USD-1,000,000USD-180,000,000USD1,583,000,000USD-132,000,000USD-18,000,000USD-1,417,000,000USD
    Other Cashflows From Financing Activities-41,000,000USD-1,001,000,000USD-42,000,000USD-54,000,000USD-582,000,000USD-91,000,000USD-82,000,000USD18,000,000USD
    Unclassified Operating Cash Flow119,000,000USD-112,000,000USD-33,000,000USD-23,000,000USD-76,000,000USD117,000,000USD11,000,000USD-18,000,000USD
    Unclassified Investing Cash Flow-113,000,000USD126,000,000USD196,000,000USD466,000,000USD-1,375,000,000USD-90,000,000USD-31,000,000USD1,302,000,000USD
    Unclassified Financing Cash Flow44,000,000USD56,000,000USD108,000,000USD1,054,000,000USD1,082,000,000USD-410,000,000USD59,000,000USD781,000,000USD
    Change To Liabilities———324,000,000USD174,000,000USD60,000,000USD-112,000,000USD144,000,000USD
    Dividends Paid———-937,000,000USD-511,000,000USD——-735,000,000USD
    Cash And Cash Equivalents Changes———801,000,000USD-575,000,000USD-240,000,000USD899,000,000USD-81,000,000USD
    Exchange Rate Changes———————-4,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2027Quarterly · 2026-06-28GeographyAsia Pacific82,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28GeographyChina56,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28GeographyEMEA368,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28GeographyUnited States And Canada653,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28ProductConsumables852,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28ProductInstruments130,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28ProductServices177,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28SegmentCore Illumina — Microarray105,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28SegmentCore Illumina — Sequencing1,054,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyAsia Pacific93,000,000USD0001110803-26-000092
    Q1 2026Quarterly · 2026-03-31GeographyChina52,000,000USD0001110803-26-000092
    Q1 2026Quarterly · 2026-03-31GeographyEMEA356,000,000USD0001110803-26-000092
    Q1 2026Quarterly · 2026-03-31GeographyUnited States And Canada590,000,000USD0001110803-26-000092
    Q1 2026Quarterly · 2026-03-31ProductConsumables797,000,000USD0001110803-26-000092
    Q1 2026Quarterly · 2026-03-31ProductInstruments120,000,000USD0001110803-26-000092
    Q1 2026Quarterly · 2026-03-31ProductServices174,000,000USD0001110803-26-000092
    Q1 2026Quarterly · 2026-03-31SegmentCore Illumina — Microarray96,000,000USD0001110803-26-000092
    Q1 2026Quarterly · 2026-03-31SegmentCore Illumina — Sequencing995,000,000USD0001110803-26-000092
    Q4 2025Quarterly · 2025-12-31ProductConsumables832,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductInstruments158,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductServices169,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentCore Illumina — Microarray94,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentCore Illumina — Sequencing1,065,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentGRAILInc.0USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductConsumables3,227,000,000USD0001110803-26-000024
    FY 2025Yearly · 2025-12-31ProductInstruments482,000,000USD0001110803-26-000024
    FY 2025Yearly · 2025-12-31ProductServices634,000,000USD0001110803-26-000024
    FY 2025Yearly · 2025-12-31SegmentCore Illumina — Microarray358,000,000USD0001110803-26-000024
    FY 2025Yearly · 2025-12-31SegmentCore Illumina — Sequencing3,985,000,000USD0001110803-26-000024
    FY 2025Yearly · 2025-12-31SegmentGRAILInc.0USD0001110803-26-000024
    Q3 2025Quarterly · 2025-09-30GeographyAmericas612,000,000USD0001110803-25-000073
    Q3 2025Quarterly · 2025-09-30GeographyAsia Pacific Middle East And Africa111,000,000USD0001110803-25-000073
    Q3 2025Quarterly · 2025-09-30GeographyChina52,000,000USD0001110803-25-000073
    Q3 2025Quarterly · 2025-09-30GeographyEurope309,000,000USD0001110803-25-000073
    Q3 2025Quarterly · 2025-09-30ProductConsumables816,000,000USD0001110803-25-000073
    Q3 2025Quarterly · 2025-09-30ProductInstruments111,000,000USD0001110803-25-000073
    Q3 2025Quarterly · 2025-09-30ProductServices157,000,000USD0001110803-25-000073
    Q3 2025Quarterly · 2025-09-30SegmentCore Illumina — Microarray83,000,000USD0001110803-25-000073
    Q3 2025Quarterly · 2025-09-30SegmentCore Illumina — Sequencing1,001,000,000USD0001110803-25-000073
    Q3 2025Quarterly · 2025-09-30SegmentGRAILInc.0USD0001110803-25-000073
    Q2 2025Quarterly · 2025-06-30GeographyAmericas586,000,000USD0001110803-25-000060
    Q2 2025Quarterly · 2025-06-30GeographyAsia Pacific Middle East And Africa100,000,000USD0001110803-25-000060
    Q2 2025Quarterly · 2025-06-30GeographyChina63,000,000USD0001110803-25-000060
    Q2 2025Quarterly · 2025-06-30GeographyEurope310,000,000USD0001110803-25-000060
    Q2 2025Quarterly · 2025-06-30ProductConsumables811,000,000USD0001110803-25-000060
    Q2 2025Quarterly · 2025-06-30ProductInstruments101,000,000USD0001110803-25-000060
    Q2 2025Quarterly · 2025-06-30ProductServices147,000,000USD0001110803-25-000060
    Q2 2025Quarterly · 2025-06-30SegmentCore Illumina — Microarray87,000,000USD0001110803-25-000060
    Q2 2025Quarterly · 2025-06-30SegmentCore Illumina — Sequencing972,000,000USD0001110803-25-000060
    Q2 2025Quarterly · 2025-06-30SegmentGRAILInc.0USD0001110803-25-000060
    Q1 2025Quarterly · 2025-03-31GeographyAsia Pacific82,000,000USD0001110803-26-000092
    Q1 2025Quarterly · 2025-03-31GeographyChina72,000,000USD0001110803-26-000092
    Q1 2025Quarterly · 2025-03-31GeographyEMEA332,000,000USD0001110803-26-000092
    Q1 2025Quarterly · 2025-03-31GeographyUnited States And Canada555,000,000USD0001110803-26-000092
    Q1 2025Quarterly · 2025-03-31ProductConsumables768,000,000USD0001110803-26-000092
    Q1 2025Quarterly · 2025-03-31ProductInstruments112,000,000USD0001110803-26-000092
    Q1 2025Quarterly · 2025-03-31ProductServices161,000,000USD0001110803-26-000092
    Q1 2025Quarterly · 2025-03-31SegmentCore Illumina — Microarray94,000,000USD0001110803-25-000046
    Q1 2025Quarterly · 2025-03-31SegmentCore Illumina — Sequencing947,000,000USD0001110803-25-000046
    Q1 2025Quarterly · 2025-03-31SegmentGRAILInc.0USD0001110803-25-000046
    Q4 2024Quarterly · 2024-12-31ProductConsumables779,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductInstruments160,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductServices165,000,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductConsumables3,155,000,000USD0001110803-26-000024
    FY 2024Yearly · 2024-12-31ProductInstruments501,000,000USD0001110803-26-000024
    FY 2024Yearly · 2024-12-31ProductServices716,000,000USD0001110803-26-000024
    Q3 2024Quarterly · 2024-09-30GeographyAmericas609,000,000USD0001110803-25-000073
    Q3 2024Quarterly · 2024-09-30GeographyAsia Pacific Middle East And Africa105,000,000USD0001110803-25-000073
    Q3 2024Quarterly · 2024-09-30GeographyChina75,000,000USD0001110803-25-000073
    Q3 2024Quarterly · 2024-09-30GeographyEurope291,000,000USD0001110803-25-000073
    Q3 2024Quarterly · 2024-09-30ProductConsumables807,000,000USD0001110803-25-000073
    Q3 2024Quarterly · 2024-09-30ProductInstruments107,000,000USD0001110803-25-000073
    Q3 2024Quarterly · 2024-09-30ProductServices166,000,000USD0001110803-25-000073
    Q3 2024Quarterly · 2024-09-30SegmentCore Illumina — Microarray85,000,000USD0001110803-25-000073
    Q3 2024Quarterly · 2024-09-30SegmentCore Illumina — Sequencing995,000,000USD0001110803-25-000073
    Q3 2024Quarterly · 2024-09-30SegmentGRAILInc.0USD0001110803-25-000073
    Q2 2024Quarterly · 2024-06-30GeographyAmericas640,000,000USD0001110803-25-000060
    Q2 2024Quarterly · 2024-06-30GeographyAsia Pacific Middle East And Africa108,000,000USD0001110803-25-000060
    Q2 2024Quarterly · 2024-06-30GeographyChina75,000,000USD0001110803-25-000060
    Q2 2024Quarterly · 2024-06-30GeographyEurope289,000,000USD0001110803-25-000060
    Q1 2024Quarterly · 2024-03-31GeographyAmericas603,000,000USD0001110803-25-000046
    Q1 2024Quarterly · 2024-03-31GeographyAsia Pacific Middle East And Africa116,000,000USD0001110803-25-000046
    Q1 2024Quarterly · 2024-03-31GeographyChina78,000,000USD0001110803-25-000046
    Q1 2024Quarterly · 2024-03-31GeographyEurope279,000,000USD0001110803-25-000046
    FY 2023Yearly · 2023-12-31ProductConsumables3,083,000,000USD0001110803-26-000024
    FY 2023Yearly · 2023-12-31ProductInstruments704,000,000USD0001110803-26-000024
    FY 2023Yearly · 2023-12-31ProductServices717,000,000USD0001110803-26-000024
    FY 2022Yearly · 2022-12-31ProductConsumables3,225,000,000USD0001110803-25-000019
    FY 2022Yearly · 2022-12-31ProductInstruments728,000,000USD0001110803-25-000019
    FY 2022Yearly · 2022-12-31ProductServices631,000,000USD0001110803-25-000019
    FY 2021Yearly · 2021-12-31ProductConsumables3,217,000,000USD0001110803-24-000010
    FY 2021Yearly · 2021-12-31ProductInstruments751,000,000USD0001110803-24-000010
    FY 2021Yearly · 2021-12-31ProductServices558,000,000USD0001110803-24-000010
    Q2 2021Quarterly · 2021-06-30SegmentCore Illumina — Microarray105,000,000USD0001110803-22-000041
    Q2 2021Quarterly · 2021-06-30SegmentCore Illumina — Sequencing1,021,000,000USD0001110803-22-000041
    Q2 2021Quarterly · 2021-06-30SegmentGRAILInc.0USD0001110803-22-000041
    FY 2020Yearly · 2020-12-31ProductConsumables2,304,000,000USD0001110803-23-000023
    FY 2020Yearly · 2020-12-31ProductInstruments431,000,000USD0001110803-23-000023
    FY 2020Yearly · 2020-12-31ProductService Other504,000,000USD0001110803-23-000023
    FY 2020Yearly · 2020-12-31SegmentConsolidated Variable Interest Entities0USD0001110803-22-000013

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.